| Author | Year of publication | Type of studies | Total sample size | Treatments | Prognosis | Overall survival time after the diagnosis of BM | Reference |
| Sena et al. | 2021 | Case report | 1 | Sipuleucel-T immunotherapy, abiraterone, prednisone, pembrolizumab, dexamethasone, craniotomy, brain-directed radiotherapy, and docetaxel chemotherapy | Passed away | — | [36] | Pikis et al. | 2021 | Case series | 46 | Prostatectomy, adjuvant radiation therapy, SRS, craniotomy, WBRT, and ADTs | Passed away | 1 year and 8 months | [37] | Parihar et al. | 2021 | Case report | 1 | Docetaxel, cabazitaxel, enzalutamide, LuPSMA radioligand therapy, alpha therapy, and Ac-PSMA, | Survived | — | [38] | Hung et al. | 2021 | Retrospective study | 204 | Docetaxel, AA, enzalutamid, and cabazitaxel | — | — | [39] | Boxley et al. | 2021 | Retrospective study | 29 | ADTs, enzalutamide, abiraterone acetate, docetaxel, and cabazitaxel | — | — | [40] | Son et al. | 2020 | Case report | 1 | Bicalutamide, degarelix, leuprorelin, WBRT, chemotherapy, and craniotomy | — | — | [30] | Shida et al. | 2020 | Case report | 3 | Bicalutamide, degarelix, brachytherapy, and WBRT | 3 passed away | 1/3/5 months | [29] | Ross et al. | 2020 | Case report | 1 | craniotomy | Survived | — | [28] | Nguyen et al. | 2020 | Retrospective cohort | 21 | WBRT | Passed away | 2/3/6 months | [42] | Marchand Crety et al. | 2020 | Case report | 1 | Hormone therapy, prostatic radiotherapy, docetaxel, and chemotherapy | Survived | — | [27] | Liu et al. | 2020 | Case report | 1 | Dexamethasone and palliative care | Passed away | 5 months | [26] | Janda et al. | 2020 | Case report | 1 | Complete androgen blocking, GnRH analog, and nonsteroidal antiandrogen, chemotherapy with analgesic radiotherapy | Passed away | 1 year and 8 months | [24] | Bhambhvani et al. | 2020 | Retrospective cohort | 31 | Stereotactic radiosurgery and surgical resection | Passed away | 4.6/13 months | [13] | Aljarba et al. | 2020 | Case report | 1 | ADTs, surgery, and palliative care | Passed away | 43 days | [32] | Ahmad et al. | 2020 | Case report | 1 | Thyroxine (steroid replacement), exposure therapy, testosterone replacement, and bicalutamide, radiotherapy | Survived | — | [43] | Kosaka et al. | 2019 | Case report | 1 | Craniotomy and ADTs, chemotherapy | — | — | [23] | Kanyilmaz et al. | 2019 | Retrospective cohort | 339 | WBRT and radiotherapy | Passed away | 4.5 months | [44] | Ishizaki et al. | 2019 | Case report | 1 | ADTs and WBRT | — | — | [22] | Hogan et al. | 2019 | Case report | 1 | SRS | Survived | — | [45] | Zanatta et al. | 2018 | Case report | 1 | Cerebellopontine angle microsurgery | Survived | — | [46] | Reinas et al. | 2018 | Case report | 1 | External beam radiotherapy, bicalutamide, right parietal craniotomy, and luteinizing | — | — | [47] | Nunno et al. | 2018 | Case report | 1 | Craniotomy | — | — | [48] | Jack et al. | 2018 | Case report | 1 | Zoladex, casodex, docetaxel, lupron, ketoconazole, lupron therapy, and WBRT | Passed away | 3 months | [49] | Campagna and Feia | 2018 | Case report | 1 | Craniotomy with biopsy and SRS | — | — | [21] | Watanabe et al. | 2017 | Case report | 1 | Androgen blockade therapy, denosumab, docetaxel, enzalutamide, abiraterone, and cabazitaxel | Survived | — | [20] | Lam et al. | 2017 | Case report | 2 | Near-total excision surgery | Survived | — | [19] | Chang et al. | 2017 | Case report | 1 | Dexamethasone, SRS, excision and orchiectomy, and left subcapsular orchiectomy | — | — | [18] | Guraya et al. | 2016 | Case report | 1 | Dexamethasone, steroid injection, levetiracetam, craniotomy, and radiation therapy | Passed away | 12 months | [50] | Barakat et al. | 2016 | Case report | 1 | Tumor resection, SRS, craniotomy, and ADTs | Survived | — | [17] | Mandaliya et al. | 2015 | Case report | 2 | Stereotactic craniotomy, WBRT, and ADTs | Survived | — | [51] | Hutton et al. | 2015 | Case report | 1 | Dexamethasone | Passed away | — | [16] | Gajewska et al. | 2015 | Case report | 1 | Cabazitaxel | — | — | [15] | Craig et al. | 2015 | Case report | 1 | Radiotherapy, ADTs, craniotomy, dexamethasone, WBRT, bicalutamide, abiraterone, and prednisone | Passed away | — | [14] | Hatzoglou et al. | 2014 | Retrospective cohort | 21 | — | Passed away | 2.8 months | [10] | Placido et al. | 2014 | Case report | 3 | Luteinizing, complete androgen blockage, bicalutamide, prostatectomy and radiation therapy, ADTs, docetaxel, abiraterone, and cabazitaxel | 2 passed away, 1 survived | — | [52] | Hazell et al. | 2013 | Case report | 4 | ADTs, radiation therapy, craniotomy, WBRT, docetaxel, prednisone, and zoledronic acid | Passed away | — | [53] | Caffo et al. | 2013 | Cohort | 9 | Castration-resistantdocetaxel-based chemotherapy, and surgery | — | — | [54] | Caffo et al. | 2012 | Case series | 22 | Undergone docetaxel-based treatment, surgery, WBRT, gamma knife, chemotherapy with docetaxel and mitoxantrone, and radiotherapy | 20 passed away | 4 months | [55] | Flannery et al. | 2010 | Case series | 10 | ADTs, WBRT, SRS, and gamma knife | 9 passed away | 2–23 months | [56] | Yamada et al. | 2009 | Case report | 1 | GnRH, cisplatin plus etoposide, and combined therapy with carboplatin plus irinotecan | Survived | — | [57] | Sweets et al. | 2009 | Case report | 1 | Chemotherapy with doxorubicin, vinblastine, nilutamide, leuprolide, prostatectomy, salvage three-dimensional conformal radiotherapy, and craniotomy | Survived | — | [58] | Kim et al. | 2008 | Case series | 5 | Gamma knife SRS and WBRT | 4 passed away | 10 months | [59] | Grenader et al. | 2007 | Case report | 1 | Dexamethasone, phenytoin, palliative radiotherapy, antiandrogen agent, bicalutamide, subcutaneous luteinizing hormone releasing hormone agonist goserelin, zoledronic acid, and craniotomy | Survived | — | [60] | Lyons et al. | 2006 | Case report | 1 | Prostatectomy, dexamethasone, phenytoin, craniotomy and resection of tumor, and external beam radiotherapy to the brain, casodex and lupron therapy | Survived | — | [61] | Wullich et al. | 2004 | Case report | 2 | Bilateral orchiectomy, fosfestrol, transurethral resection, craniotomy, and WBRT | Passed away | 1-2 month | [62] | Schoenwaelder et al. | 2004 | Case report | 1 | Dexamethasone, phenytoin, posterior fossa craniectomy, insertion of a ventriculoperitoneal shunt for hydrocephalus, oral antiandrogen therapy, and palliative radiotherapy | Passed away | 4 months | [63] | Tremont-Lukats et al. | 2003 | Case series | 103 | Supportive care and SRS | Passed away | 1 month | [9] | Erasmus et al. | 2002 | Case report | 1 | Hormonal therapy(cyproterone acetate), craniotomy, and radiation therapy | Passed away | — | [64] | Minami et al. | 2001 | Case report | 1 | Transurethral resection of prostate, hormone therapy with goserelin acetate and flutamide, and intermittent arterial infusion chemotherapy with cisplatin and pirarubicin | Passed away | Less than 1 month | [65] | Behrens et al. | 2001 | Case report | 1 | Dexamethasone, phenytoin, craniotomy | — | — | [66] | Garcia-Morales et al. | 2000 | Case report | 1 | chemotherapy, radiotherapy, and craniotomy | — | — | [67] | Fervenza et al. | 2000 | Case report | 1 | WBRT, SRS, craniotomy, and ADTs | Survived | — | [68] | Hayashi et al. | 1998 | Case report | 1 | Prostatectomy and craniotomy | Survived | — | [69] | Zhang et al. | 1997 | Case report | 1 | Prostatectomy, ifosfamide, local radiation therapy, and craniotomy | Passed away | 19 months | [70] | Leibman et al. | 1995 | Case report | 2 | Hormonal therapy (leuprolide and flutamide) and chemotherapy (cyclophosphamide and methotrexate), and WBRT | Passed away | — | [71] | Bland et al. | 1992 | Case report | 1 | Radiation therapy and bilateral orchiectomy | Survived | — | [72] | Lynes et al. | 1986 | Case report | 2 | WBRT, suboccipital craniotomy, bilateral orchiectomy, doxorubicin hydrochloride (adriamycin), and frontal craniotomy | 1 survived, 1 passed away | 9 months | [73] | Sarma et al. | 1983 | Case report | 4 | Transurethral resection and bilateral orchiectomy | Passed away | — | [74] |
|
|